Neutrophilic dermatoses

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 14.05.2025

Dieser Artikel auf Deutsch

Synonym(s)

Dermatoses neutrophils; Dermatoses reactive neutrophils; Neutrophilic dermatoses; Neutrophil reactive dermatoses; Reactive neutrophilic dermatoses

Definition
This section has been translated automatically.

Summarizing term for an etiopathogenetically and clinically heterogeneous group of diseases characterized by varying degrees of systemic symptoms that are often febrile, reactive and frequently arthritic. The associated skin changes are defined histopathologically by neutrophilic diffuse dermatitis without evidence of vasculitis (exclusion criterion). On the one hand,"acute febrile neutrophilic dermatosis (Sweet syndrome)" is to be regarded as the prototype of this group of diseases. On the other hand, autoinflammatory (non-bacterial) pustuloses belong to this group of diseases.

Classification
This section has been translated automatically.

In the following, "neutrophilic" dermatoses are listed in alphabetical order, whereby the classification into "in the broader and narrower sense" must be considered provisional. "Neutrophilic" dermatoses are often accompanied by reactive arthritis (see also dermatitis-arthritis syndromes) or they are characterized by a primarily arthritic constellation. They have also been described as ADRs during treatment with TNF-alpha inhibitors (Calabrese L et al. 2024)

Neutrophilic dermatoses (in the narrower sense):

Neutrophilic dermatoses (in the broader sense):

Etiopathogenesis
This section has been translated automatically.

The pathogenesis of this clinically very different group of diseases has not yet been clarified. However, it is likely that they are not uniform but polyetiological - autoimmunological, vasculitic, infectious-allergic - in nature.

It can be assumed that all neutrophilic dermatoses are autoinflammatory in nature with predominant congenital immune dysfunction. Inflammatory mediators such as interleukin-1beta, TNF-alpha, interleukin-8, interleukin-17 and interleukin-36, which ultimately promote the activation and migration of neutrophils into the skin, are overexpressed. The occurrence of neutrophilic dermatoses in connection with a so-called "paradoxical skin reaction" as a side effect of therapy with TNF-alpha inhibitors is noteworthy.

Clinic
This section has been translated automatically.

The skin symptoms vary considerably from clinical picture to clinical picture. They range from vesiculo-pustular to papular, plaque-like, discoid, anular or polycyclic lesions. The polymorphism of the clinical symptoms in one and the same patient is characteristic, and depending on the localization of the infiltrate, the skin changes can be classified as follows:

  • Superficial neutrophilic dermatoses
  • Plaque-like neutrophilic dermatoses
  • Deep neutrophilic dermatoses.

A characteristic feature of neutrophilic dermatoses is the polymorphism of clinical symptoms in one and the same patient.

Laboratory
This section has been translated automatically.

Mostly accentuated inflammatory parameters (leukocytosis with neutrophilia, CRP and BSG elevations).

Therapy
This section has been translated automatically.

S. under the individual clinical pictures

Literature
This section has been translated automatically.

  1. Calabrese L et al. (2024) Paradoxical skin reaction to certolizumab, an overlap of neutrophilic dermatoses. J Dtsch Dermatol Ges 22:438-441.

  2. Kühl E (2010) Reactive neutrophilic dermatoses. Akt Dermatol 36: 165-170

  3. Callen JP (2002) Neutrophilic dermatoses. Dermatol Clin 20: 409-419

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 14.05.2025